The increased risks of using a celebrity for drug promotion emerged in a new US Food and Drug Administration advertising and promotion untitled letter for AbbVie Inc.’s migraine drug Ubrelvy.
Celebs Bring Extra Scrutiny To Advertisements, US FDA Tells AbbVie
AbbVie’s migraine ad overstates the drug’s benefit, a problem that is amplified by using a celebrity, the agency says.
